The increasing number of tuberculosis (TB) infections with multidrug resistant (MDR) Mycobacterium tuberculosis strains causes a severe worldwide health problem, necessitating the development of new antibiotics. A novel drug, the diarylquinoline TMC207, was found to be highly effective in the treatment of MDR-TB. It was reported that the drug targets the rotor ring of the energy converting enzyme F 1 F o -ATP synthase, which is essential for the survival of mycobacteria. However, structural and biochemical information about the precise binding site of TMC207 and its mechanism of action are not known at the level of the isolated ATP synthase or its rotor ring complex. We performed ATP synthesis experiments on a mycobacterial ATP synthase, including inhibition studies using two different antibiotics, TMC207 and mefloquine. TMC207 inhibited 50% of ATP synthesis at 0.03 μM. In contrast, mefloquine was less active, but nevertheless still an efficient inhibitor of the mycobacterial ATP synthase at 15 μM (IC 50 ). We then purified a mycobacterial ATP synthase rotor (c-) ring and established a drug competition assay using the well known ATP synthesis inhibitor dicyclohexylcarbodiimide (DCCD). The results show that TMC207 competes with DCCD at the proton binding site of the c-ring. This is direct biochemical proof that the c-ring's ion binding site is the actual target of the drug, to which it binds with high affinity and specificity. Similar results were found for mefloquine, although we detected lower affinities for the proton binding site. To further explore the highly specific drug-target interaction of TMC207 with the mycobacterial c-ring, we aim to solve its structure in complex with TMC207. X-ray diffracting 3D crystals of the rotor ring-drug complex are available. This work provides insights into the specific interaction of the isolated mycobacterial ATP synthase rotor ring with a novel and highly potent drug, in the perspective to treat infections in patients with MDR M. tuberculosis strains. Based on these results, an optimisation of TMC207 derivatives and further development of drugs, which target the ATP synthase to treat TB becomes conceivable. We studied ADP-inhibition on inverted membranes from Escherichia coli. ATP hydrolysis is accompanied by stoichiometric proton release at pH N 7.2. This acidification was measured by pH indicator phenol red absorption changes.
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We studied wild-type enzyme at room temperature (24°C ) and 37°C. At room temperature ADP-inhibition was weaker than at 37°C. Also we studied the influence of inorganic phosphate on the ADPinhibition of the enzyme. In the presence of phosphate ADPinhibition increased in the wild-type enzyme.
It was shown previously [1] that mutation Met23Lys in the γ subunit of the enzyme enhanced ADP-inhibition compared to the wild-type enzyme in purple bacteria Rhodobacter capsulatus. Our results indicate that mutation showed the same effect on membranes from E.coli at 37°C, but at room temperature this effect was reversed as in the wild type. Inorganic phosphate enhanced ADP-inhibition of the enzyme carrying this mutation.
We also found that enzyme with mutation βLeu249Gln situated on the interface between α and β subunits had weak ADP-inhibition at 24°C, but at 37°C the inhibition was stronger. In contrast to γMet23Lys and wild-type, addition of phosphate reduced ADPinhibition of the βL249Q mutant. Our results allow us to suppose that this position is important for modulation of ADP-inhibition by phosphate. The mitochondrial F 1 F 0 -ATP synthase is one of the most ubiquitously studied enzymes. In physiological conditions it carries out ATP synthesis, utilizing the H + gradient generated by the Electron Respiratory Chain. When mitochondrial function is compromised, the enzyme acts as ATP consumer depleting cells from ATP which is inhibited by IF 1 -the natural endogenous inhibitor of ATP synthase [1] . Recent reports, including ours [2] , have suggested the presence of subunits or the whole complex on the cell surface of various cell types [3] . Both by immunofluorescent and western blotting analyses, we found that IF 1 co-localizes with the ATP synthase (β-subunit) and flotillin, a lipid raft marker, on the cell surface of HeLa cells. The OSCP, a subunit of the ATP synthase assembled at very late stage, was also found to pair the β-subunit and IF 1 in non-permeabilized cells, suggesting the presence of a small functional mitochondria-like organization. Notably, cholesterol loading, performed at different time intervals, reduced the mitochondrial content of IF 1 , with a parallel increase of the ectopic expression.
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In conclusion, our data report that IF 1 (re)localizes in the lipid rafts of plasma membranes in association with the F 1 F 0 -ATPase depending on the cholesterol level to which cells were exposed. The higher surface expression of IF 1 could therefore represent a mechanism to preserve ATP level on the extra cellular space sparing this from the F 1 F 0 -ATPase mediated hydrolysis.
AKR is supported by a fellowship from Fondazione Cassa di Risparmio di Padova e Rovigo. In the bacterium Fusobacterium nucleatum, a Na + motive force is generated by the fermentation of glutamate via the hydroxyglutarate pathway, which involves a Na + pump, the glutaconyl-CoA-decarboxylase. We hypothesized that F. nucleatum contains a Na + -dependent ATP synthase, which directly uses this smf to produce ATP. Using a heterologous hybrid ATP synthase expression system, we produced and isolated the F. nucleatum c-ring and performed a biochemical labeling study using a fluorescent analogue of the ATP synthase inhibitor dicyclohexylcarbodiimide. The study demonstrates that this membrane rotor is coupled to Na + at neutral pH and in the presence of 10 mM Na + . We created a homology model of this c-ring and carried out molecular simulations to assess the characteristics of its ion-binding sites. The calculations support the notion that this rotor is coupled to Na + under physiological conditions, as a result of the amino-acid make-up of the ion-coordination shell, which includes the universally conserved carboxylate side-chain as well as other polar moieties from the protein and a water molecule. Interestingly, among these there is a second glutamate side chain, which our calculations suggest is constitutively protonated, effectively replacing a glutamine in homologous c-rings. Hence it confers neither H + coupling nor a significantly more pronounced Na + specificity. We succeeded to crystallize this c-ring and to solve its structure by X-ray diffraction at 2.2 Å resolution. The experimental structure shows that the ring contains 11 c-subunits, which form an hourglass-shaped cylinder with a central pore. Each c-subunit consists of an a-helical hairpin with the N-and C-termini on the periplasmic side. The structure also shows the location of the 11 Na + binding sites, formed between neighboring c-subunits on the outer surface of the ring, at the membrane middle. Importantly, the Na + coordination network revealed by the crystal structure is entirely consistent with the presence of an additional H + , shared between the two carboxylate side-chains in the binding site. Such a constellation is feasible considering that F. nucleatum faces temporal chemical changes of its natural habitat, e.g. the human mouth flora. As this c-ring structure deviates significantly from the structure of a eukaryotic c-ring, this work provides the structural basis for screening of novel drugs against the ATP synthase of the opportunistic pathogenic bacterium F. nucleatum. Previously, we have developed the highly reproducible, simple procedures for the preparation of active proteoliposomes and for kinetic analysis of ATP synthesis which was driven by acid-base transition and valinomycin-mediated K + diffusion potential, and precisely shown the kinetic equivalence between ΔpH and Δψ [1] . Here, to determine the H + /ATP ratio and the free energy of ATP synthesis for the thermophilic Bacillus PS3 ATP synthase, we examined how the proton motive force is balanced by counteracting ATP hydrolysis [2] . We measured the rates of ATP synthesis and hydrolysis with luciferin-lucifease system as a function of the proton motive force. For various nucleotide conditions we determined the equilibrium proton motive force at which 
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